Health Care/Hospital

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the U.S. FDA (FDA). T...

2021-04-07 08:22 23406

EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery

SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ -- EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc ( Princeton, NJ, USA), (hereafter jointly referred to as EDDA Techno...

2021-04-07 07:00 41595

Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S

SEONGNAM, South Korea, April 6, 2021 /PRNewswire/ -- Bridge Biotherapeutics Inc.(288330 KQ), a clinical-stage biotech company headquartered in Seongnam, Republic of Korea, announced that the company has initiated the Phase 1/2 clinical trial assessing safety, tolerability, and anti-tumor activity...

2021-04-07 06:00 5759

Essence Group Major Supply Chain Initiative Helps Ensure Continued Customer Service for its Partners Throughout COVID-19 Lockdown

HERZLIYA, Israel, April 7, 2021 /PRNewswire/ -- Essence Group , a leading provider of IoT solutions for the global security and care markets, today provided details of its aggressive supply chain initiative, that mitigated the global supply chain disruption caused b...

2021-04-07 06:00 4076

Shanghai Genechem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies

SHANGHAI, April 6,, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global bioph...

2021-04-06 22:26 39628

Inner Armour Sports Nutrition Brand Sold to New Owners

Randy Couture, six-time UFC Champion, part of new ownership team LAS VEGAS, April 6, 2021 /PRNewswire/ -- After more than a decade providing athletes with the most powerful sports supplements in the world,Inner Armour Sports Nutrition is ready to step into the ring with a new ownership team that...

2021-04-06 21:30 3522

Hyperice Names Tony Finau, Sungjae Im and Cameron Smith to Athlete Roster Ahead of 2021 Masters Tournament

Rising Stars Represent Future of Golf and Extend Global Presence of PGA TOUR Partnership Hypervolt GO Approved for On Course Use During Tournament Play IRVINE, Calif., April 6, 2021 /PRNewswire/ -- Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic...

2021-04-06 21:00 6022

Gan & Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma

BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products ...

2021-04-06 20:53 5235

Brattea, a Leading Renal Denervation Company in China, Completes over $US20 Million Series B+ Financing, led by Kuanping Capital

SHANGHAI, April 6, 2021 /PRNewswire/ -- Brattea, a leading renal denervation (RDN) medical technology company inChina, announced today its successful completion of over$US20 million Series B+ financing led by healthcare private equity fund Kuanping Capital. New investors include Hengxu Capital, P...

2021-04-06 20:00 41563

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer

- MitoImmune initiates a Phase 2 trial of oral mucositis (OM) prevention in the first half of 2021 in the US and Korea, and is expanding OM treatment into hematopoietic stem cell transplantation clinical trials SEOUL, South Korea, April 6, 2021 /PRNewswire/ -- MitoIm...

2021-04-06 20:00 3145

Smart Glove Acclaimed by Frost & Sullivan for Introducing Several First-of-their-kind Medical Gloves to the Market

Smart Glove is a global leading supplier of nitrile, latex, vinyl, and other synthetic gloves for industries ranging from healthcare to food and beverage KUALA LUMPUR, Malaysia, April 6, 2021 /PRNewswire/ -- Based on its recent analysis of the global medical gloves market, Frost & Sullivan recogn...

2021-04-06 16:23 2536

How to Power Your Hospital with Artificial Intelligence in Medical Imaging

Frost & Sullivan's white paper highlights the process of creating an AI strategy for your imaging department SANTA CLARA, Calif., April 6, 2021 /PRNewswire/ -- The medical imaging industry is in the midst of large-scale transformation, largely driven by the advancements in technologies such as a...

2021-04-06 14:02 3126

Review of Myopia Management and Plano Announce New Content Partnership

SINGAPORE, April 6, 2021 /PRNewswire/ -- Review of Myopia Management  (RMM) is pleased to announce a new partnership with theSingapore-based Healthtech company, Plano Pte Ltd . Under their new agreement,RMM and Plano will produce new educational con...

2021-04-06 11:00 5482

Agoda: Asian governments should prepare for flexible quarantine options to complement the vaccine roll-out

SINGAPORE, April 6, 2021 /PRNewswire/ -- Confidence in the vaccine rollouts, discussions around COVID-19 passports and alternative state quarantine announcements have triggered an increase in international travel searches, according to digital travel platform Agoda.com.  

2021-04-06 08:28 5132

Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma

SHANGHAI and HONG KONG, April 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-04-06 08:00 10294

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

* Crossover allows participants to continue in trials and remain blinded * Ensures that all trial participants receive active vaccine * South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned GAITHERSBURG, Md., April 6, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...

2021-04-06 05:00 7005

Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation With $100 Million Backing

Backed by Royal DSM, Hologram seeks to disrupt nutrition marketplace by offering consumer-facing personalized solutions  BOSTON and NEW YORK, April 6, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in nutrition, health and sustainable living, announced the launch of Hologram Sci...

2021-04-06 04:54 5841

Thailand BOI Okays Biotech Projects Worth 2.4 Bln Baht in Total Investment

BANGKOK, April 5, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) said today it has recently approved new projects in the field of advanced biotechnology, worth a combined2.4 billion baht (around USD78 million) in investment, reflecting the increased interest of local and foreign inve...

2021-04-05 23:03 5884

AI-Based Imaging Analysis Tools and Cloud-Based Deployments to Bolster the Global Digital Pathology Market

SANTA CLARA, Calif., April 5, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market, finds that this market is estimated to hit $825.9 million by 2025 from $513.3 million in 2019 at a compoun...

2021-04-05 18:03 3696

Pfizer collaborates with DoctorOnCall to improve health literacy and patient care in Malaysia

KUALA LUMPUR, Malaysia, April 5, 2021 /PRNewswire/ -- Pfizer today announced its collaboration with DoctorOnCall to launch a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health. Catering to an increasingly tech-savvy an...

2021-04-05 11:32 20489
1 ... 814815816817818819820 ... 858